Abstract: Disclosed is a pharmaceutical composition for treating chronic obstructive pulmonary disease, comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method for treating chronic obstructive pulmonary disease in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent.

Abstract: Disclosed is a pharmaceutical composition for treating ischemic stroke, comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method for treating ischemic stroke in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. In addition, a method for promoting secretion of hepatocyte growth factor by human mesenchymal stem cells is disclosed.

Abstract: Disclosed is a method for identifying a greater risk for developing bronchopulmonary dysplasia (BPD) of a preterm infant. The method comprises obtaining a genomic DNA sample from the preterm infant's mother, genotyping rs2280789 SNP in the RANTES gene, and determining the preterm infant as being at risk of developing BPD if the genotype of the rs2280789 SNP is CC. Also disclosed are a primer pair for genotyping rs2280789 SNP in the RANTES gene, and a method thereof.

Abstract: Disclosed is a method for identifying a greater risk for developing bronchopulmonary dysplasia (BPD) of a preterm infant. The method comprises obtaining a genomic DNA sample from the preterm infant's mother, genotyping rs1800566 SNP in the NQO1 gene, and determining the preterm infant as being at risk of developing BPD if the genotype of the rs1800566 SNP is TT. Also disclosed are a primer pair for genotyping rs1800566 SNP in the NQO1 gene, and a method thereof.

Abstract: Disclosed is a method of identifying a greater risk for developing bronchopulmonary dysplasia (BPD) in a preterm infant. The method comprises obtaining a genomic DNA sample from the preterm infant's mother, identifying the nucleotide of rs2280789 SNP in the RANTES gene and the nucleotide of rs1800566 SNP in the NQO1 gene, and determining the preterm infant as being at risk of developing BPD when the genotype of rs2280789 SNP carries C nucleotide and the genotype of rs1800566 SNP carries T nucleotide.

Abstract: Provided is a method for determining the risk of preterm labor in a pregnant female subject. The method comprises detecting the expression level of one or more markers selected from the group consisting of TMEM200A, TMEM108 and GXYLT2, in a sample derived from the pregnant female subject.

Abstract: Provided is a method for determining the risk of bronchopulmonary dysplasia (BPD) of a preterm infant. The method comprises detecting the expression level of EPHB2 in a primary culture of mesenchymal stem or stromal cells (MSCs) derived from a placenta-related tissue of the infant's mother or umbilical cord blood of the infant.

Abstract: A method of distinguishing mesenchymal stem cells (MSCs) from fibroblasts is provided. Also provided is a method of increasing a purity of mesenchymal stem cells (MSCs) population in a cell culture. The above-mentioned methods each comprise a step of sorting or isolating the cells by a marker of CD146 from a cell culture derived from a placenta-related tissue. Further provided is a method of assessing purity of mesenchymal stem cells (MSCs) in a cell culture derived from a placenta-related tissue, comprising determining the percentage of cells expressing CD146 in the culture.

Abstract: A method of distinguishing mesenchymal stem cells (MSCs) in a primary culture of cells derived from a placenta-related tissue is provided. Also provided is a method of increasing the purity of MSC population in a primary culture of cells derived from a placenta-related tissue. Further provided is a method of isolating a MSC population which is more responsive in an inflammatory environment. Said methods each comprise a step of sorting the cells by a marker of EphA2.

Abstract: A method of distinguishing mesenchymal stem cells (MSCs) in a primary culture of cells derived from a placenta-related tissue is provided. Also provided is a method of increasing the purity of MSC population in a primary culture of cells derived from a placenta-related tissue. Further provided is a method of isolating a MSC population which is more responsive in an inflammatory environment. Said methods each comprise a step of sorting the cells by a marker of EphA2.

Abstract: Disclosure is a detachable image input/output device which is applicable to detachably connect to one of temples of a glasses frame, and comprises an L-shaped body, an image capture module and an image display module. A side of the L-shaped body has a connecting part, and the side of the L-shaped body corresponds to the temple, the L-shaped body connects to the temple by the connection part, an end of the L-shaped body has a bending part, and the bending part of the L-shaped body being bent to a direction perpendicular to the temple. The image capture module is disposed at the bending part of the L-shaped body and adjacent to the bending position of the L-shaped body. The image display module is disposed at the bending part of the L-shaped body and far away the bending position of the L-shaped body.

Abstract: Provided discloses an electronic device for calculating physical energy consumption including a gravity sensing module, a storage module, a processing module, and a touch control display module. The gravity sensing module detects at least one movement of the electronic device for calculating physical energy consumption to generate at least one movement signal. The storage module stores a plural physical training mode and a plural predetermined exercise value. The processing module connects to the gravity sensing module and the storage module, the processing module receives at least one movement signal and generates at least one active value depending on the movement signal, and subtracts at least one active value from the predetermined exercise value corresponding to one of the physical training modes to generate at least one exercising consumption signal. The touch control display module connects to the processing module, and receives and displays at least one exercising consumption signal.

Abstract: Disclosure is a flexible image input/output device comprising a first body, a second body and a flexible member. The first body has an image capture module generating a first image signal. The second body separates from the first body and has an image display module receiving the first image signal and displaying a first image. The flexible member, of which one end connects to the first body and another end connects to the second body to transmit the first image signal from the image capture module to the image display module.